Oral abstracts

ESVC – European Society of Veterinary Cardiology

Thursday 5 September

ESVC-O-1

08.15-08.30

Gardner

Six-lead electrocardiography in predicting subclinical hypertrophic cardiomyopathy in cats

ESVC-O-2

08.30-08.45

Maffei

New electrocardiographic algorithm for the diagnosis of fast supraventricular tachycardias in dogs

ESVC-O-3

08.45-09.00

Maffei

Twelve-lead electrocardiographic differentiation of monomorphic ventricular tachycardia versus bundle branch block in dogs

ESVC-O-4

12.05-12.20

Bagardi

Three step-based electrocardiographic algorithm for the identification of accessory pathway location in dogs with ventricular pre-excitation

ESVC-O-5

12.20-12.35

Nii

Clinical utility of pharmacological defibrillation during canine mitral valve repair

ESVC-O-6

12.35-12.50

Atkinson

Echocardiographic indices of reverse cardiac remodeling and outcome predictors in dogs undergoing mitral valve repair

ESVC-O-7

14.25-14.40

Shinoda

Tricuspid regurgitation velocity improves after mitral valve repair in dogs but is not associated with long-term mortality

ESVC-O-8

14.40-14.55

Isayama

Trigone-based sizing method and proposal for mitral valve annuloplasty surgery in dogs

ESVC-O-9

14.55-15.10

Franchini

Three-dimensional echocardiographic determinants of the age of onset of myxomatous mitral valve disease in Cavalier King Charles Spaniels dogs

ESVC-O-10

15.10-15.25

Ferri

Assessment of Pulmonary Veins Diameter in Cavalier King Charles Spaniels with Degenerative Mitral Valve Disease

ESVC-O-11

15.25-15.40

Novo Matos

Comparison of left ventricular wall measurements obtained from different echocardiographic views: a study in 408 cats

ESVC-O-12

15.40-15.55

Oricco

Mitral to aortic velocity-time integral ratio to estimate the regurgitant fraction in dogs with myxomatous mitral valve disease.

ESVC-O-13

15.55-16.10

Korzybska

Use of the Subcostal View for Obtaining Aortic Spectral Doppler Flow Velocities in Cats.

ESVC-O-14

16.10-16.25

Showers

Comparison of cardiac output measurements utilizing three-dimensional transesophageal echocardiography and two-dimensional transesophageal cardiography

ESVC-O-15

16.25-16.40

Kennedy

Comparing pulmonic and aortic velocity-time integral-derived cardiac output parameters in dogs receiving intravenous fluid challenges: a preliminary study

Friday 6 September 2024

ESVC-O-16

14.25-14.40

Mazzarella

Red blood cell glycocalyx damage in canine myxomatous mitral valve disease

ESVC-O-17

14.40-14.55

Patata

Echocardiographic left ventricular wall thickness in cats: the role of the breed and the body weight

ESVC-O-18

14.55-15.10

Papa

Congenital cardiopathies in cats: a retrospective analysis in a single referral centre.

ESVC-O-19

15.10-15.25

Pierce

The BEAMS Study - Baseline Evaluation And Management of Scatter radiation using RADPAD radiation absorbing drapes during veterinary interventional cardiac procedures

ESVC-O-20

15.25-15.40

Galanakis

Veterinary cardiologists’ preferences regarding interventional cardiac procedures.

ESVC-O-21

15.40-15.55

Dickson

Validation of a physical examination algorithm in dyspnoeic cats presenting to general practice: the RAPID CAT 2 study

ESVC-O-22

16.30-16.45

Petchdee

Rivaroxaban versus enoxaparin plus clopidogrel therapy in cats with thromboembolic disease

ESVC-O-23

16.45-17.00

Merveille

Observational longitudinal study of pulmonary hypertension in West Highland white terriers affected with canine idiopathic pulmonary fibrosis

ESVC-O-24

17.00-17.15

Merveille

Acute and chronic pulmonary thromboembolism in dogs : a prospective clinical study.

ESVC-O-25

17.15-17.30

Goya

Effects of adjunct ambrisentan therapy on clinical signs, oxygenation capacity, and echocardiographic variables in dogs with pulmonary hypertension resistant to sildenafil therapy

ESVC-O-26

17.30-17.45

Lombardo

Subcutaneous furosemide therapy for chronic management of refractory congestive heart failure in dogs and cats

ESVC-O-27

17.45-18.00

Murphy

Management and short-term outcome of 74 cases of acute congestive heart failure in cats (2017-2022)

SCH – Society of Comparative Hepatology

Thursday 5 September

SCH-O-1

08.00-08.15

Phillips

Altered serum amino acids profiles in dogs with liver disease

SCH-O-2

08.15-08.30

Lopez-gomez

Effectiveness and associated adverse effects of telmisartan in the treatment of portal hypertension secondary to liver disease in dogs 

SCH-O-3

08.30-08.45

Dröes

Intact thrombin generation potential in dogs with different liver diseases

SCH-O-4

08.45-09.00

Habermaass

Fecal bile acids in canine chronic liver disease: results in 46 dogs

SCH-O-5

09.00-09.15

Johnston

Does canine schistosomiasis promote hepatocellular carcinogenesis? 

SCH-O-6

09.15-09.30

Retrospective analysis of the incidence and clinicopathological findings associated with ammonium urate urolithiasis in dogs with congenital hepatic vascular anomalies; 378 cases (2010-2023)

SCH-O-7

09.30-09.45

Petibon

Risk factors for short-term mortality of hepatic lipidosis: a multicentre retrospective study of 162 cats

SCH-O-8

09.45-10.00

Fong

Complications associated with hepatic fine needle aspiration in cats; a retrospective study.

SCH-O-9

10.00-10.15

Mendoza

The effect of transdermal mirtazapine on the appetite recovery time in hospitalized cats with hepatobiliary disease: a prospective study

SCH-O-10

10.15-10.30

Feline emphysematous cholecystitis, a descriptive study.

ESVCP – European Society of Veterinary Clinical Pathology

Thursday 5 September

ESVCP-O-1

14.25-14.40

Weber

Performance of the VetScan Imagyst in point-of-care detection of Giardia duodenalis in canine fecal samples

ESVCP-O-2

14.40-14.55

Espada Castro

Evaluation of a gel-based method for canine major crossmatch testing 

ESVCP-O-3

14.55-15.10

Machiels

Utility of the IDEXX ProCyte Dx analyser for the measurement of total cell counts in bronchoalveolar lavage fluid from dogs with lower airway disease  

ESVCP-O-4

15.10-15.25

Cattaneo

Serum symmetric dimethylarginine (SDMA) concentrations are not influenced by systemic inflammation in cats

ESVCP-O-5

15.25-15.40

Reeves

The clinical utility of C-reactive protein in the discrimination of three types of common meningitis presentations in Southeast Queensland Australia

ESVCP-O-6

15.40-15.55

Kaufmann

Prospective evaluation of the utility of the predicted ionized calcium in dogs in clinical settings

ESVCP-O-7

15.55-16.10

von Luckner

Introducing novel Diagnostics of the Feline Renine Angiontensin Aldosterone System by Tandem Mass Spectrometry

ESVCP-O-8

16.10-16.25

Palerme

The Use of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Biomarker for Septic Effusions in Dogs

ESVCP-O-9

16.25-16.40

Chrysovergi

Bioactive adrenomedullin as a diagnostic and prognostic biomarker in dogs with sepsis and septic shock.

ESVNU – European Society of Veterinary Nephrology and Urology

Thursday 5 September

ESVNU-O-1

09.00-09.15

Rossi

Exploring the impact of kidney biopsy on survival in dogs with glomerular disease: insights from the european veterinary renal pathology service (evrps)

ESVNU-O-2

09.15-09.30

Man

Expression of β thymosin peptides in cat kidneys and changes associated with chronic kidney disease

ESVNU-O-3

09.30-09.45

Remmel

Usefulness of parathormone, calcitriol and parathyroid glands ultrasound in differentiating acute kidney injury and acute on chronic kidney disease in dogs.

ESVNU-O-4

09.45-10.00

Corsaletti

Comparison of long-term outcomes after SUB implantation in cats with and without systematic flush: a retrospective study of 128 cases (2013-2024)

ESVNU-O-5

10.00-10.15

Gravgaard

Increased Serum Amyloid A in cats with pyelonephritis

ESVNU-O-6

10.15-10.30

Erika Leth Vasby

Urinary levels of interleukin-8 in dogs with bacteriuria

ESVNU-O-7

11.20-11.35

Lopez

Evaluation of probiotic supplementation in dogs with chronic kidney disease

ESVNU-O-8

11.35-11.50

Sugar

Clinical Findings, Prognostic Factors and Outcomes of Feline Protein Losing Nephropathy secondary to glomerular disease: A Retrospective Study

ESVNU-O-9

11.50-12.05

Bernard

Effects and remanence of short-course of telmisartan or benazepril on renal function of healthy dogs: a prospective, cross-over, double-masked, placebo-controlled study

Friday 6 September 2024

ESVNU-O-10

09.00-09.15

Gordin

Urinary Clusterin and Cystatin B in Dogs with Spontaneous Acute Kidney Injury

ESVNU-O-11

09.15-09.30

Jaturunratsamee

Innovation of polycystic kidney disease test kit by loop-mediated isothermal amplification

ESVNU-O-12

09.30-09.45

Fidanzio

Evaluation of serum C-reactive protein in dogs with urinary tract infections

ESVNU-O-13

09.45-10.00

Lunet Marques

New insights into the role of adrenal function in chronic kidney disease

ESVNU-O-14

10.00-10.15

Pichard

Mycoplasma-associated urethritis in dogs: A case series

ESVNU-O-15

10.15-10.30

Marynissen

Renal health in aging apparently healthy dogs: panel of serum and urinary biomarkers

ESCG – European Society of Comparative Gastroenterology

Friday 6 September 2024

ESCG-O-1

08.15-08.30

Winston

Ursodiol Administration Modulates the Intestinal Ecosystem of Dogs and Cats

ESCG-O-2

08.30-08.45

Suchodolski

Effect of metronidazole on fecal microbiome, metabolome, and serum uremic toxins in healthy adult cats

ESCG-O-3

08.45-09.00

Simpson

Limited ingredient diets remodel the enteric microbiome and serum metabolome of dogs with food responsive enteropathy.

ESCG-O-4

09.00-09.15

Rowe

Fecal Bile Acid Dysmetabolism is Correlated with Relative Abundance of Peptacetobacter hiranonis and Oscillospirales in Cats with Chronic Kidney Disease

ESCG-O-5

09.15-09.30

Winston

Multi-omic Approach Identifies Expanded Bile Acid Pools, New Microbially Conjugated Bile Acids, and Bile Acid Biotransformation Genes in the Canine and Feline Gut Microbiota

ESCG-O-6

09.30-09.45

Busch

Recovery of fecal fatty acid and sterol profiles in dogs with acute hemorrhagic diarrhea syndrome

ESCG-O-7

09.45-10.00

Rowe

Metagenomic Sequencing Identifies Specific Gut Microbes Associated with Resolution of Canine Acute Noninfectious Colitis

ESCG-O-8

10.00-10.15

Chen

Functional gene profile and targeted metabolome in dogs with chronic enteropathy

ESCG-O-9

10.15-10.30

Barko

Disruptions in microbial tryptophan catabolism are associated with fecal abundance of Bifidobacterium and disease activity indices in cats with chronic enteropathies

ESCG-O-10

11.20-11.35

Benoit

Prediction of mortality and intensive care unit length of stay in dogs with acute pancreatitis using machine learning algorithms: a pilot study on 215 dogs

ESCG-O-11

11.35-11.50

Wu

Re-evaluation of the Reference Interval and Cut-off Value for Canine Trypsin-like Immunoreactivity Assay

ESCG-O-12

11.50-12.05

Sidler

Comparison of clinical, laboratory, and ultrasonographic findings in dogs with acute pancreatitis and acute idiopathic gastrointestinal disease

ESCG-O-13

12.05-12.20

Bigay

Use of budesonide in feline chronic enteropathies: a retrospective study of 102 cases

ESCG-O-14

12.20-12.35

Kaufmann

Functional dyspepsia in dogs and humans: a comparative approach and a retrospective study of 29 canine cases

ESCG-O-15

12.35-12.50

Freisleben

Occurrence of clinical signs in young dogs with and without Giardia duodenalis infection

ESVIM – European Society of Veterinary Internal Medicine

Saturday 7 September

ESVIM-O-1

08.00-08.15

Henry

Canine chronic idiopathic rhinitis, management and outcome: a single centre retrospective observational study.

ESVIM-O-2

08.15-08.30

Vilcot

Association between signalment, clinical signs and nasal diseases type and location in dogs and cats

ESVIM-O-3

08.30-08.45

Neittaanmäki

Histopathological findings in the nasal biopsies of dogs without nasal signs compared to dogs with chronic inflammatory rhinitis

ESVIM-O-4

08.45-09.00

Grobman

Evaluation of Silent Aspiration in Dogs using Videofluoroscopic Swallow Studies

ESVIM-O-5

14.25-14.40

Buton

Description and comparison of efficacy and safety of blind bronchoalveolar lavage using a sterile endotracheal tube or direct laryngo-tracheal catheterization in 51 cats

ESVIM-O-6

14.40-14.55

Chang

Presence of fungi from bronchoalveolar lavage specimens in clinical cats and dogs – a retrospective evaluation over a ten-year period

ESVIM-O-7

14.55-15.10

Parreño

Comparison of cytological findings after obtaining two consecutive samples of bronchoalveolar lavages in dogs and cats: a prospective study of 21 cases

ESVIM-O-8

15.10-15.25

Robin

Clinical and prognostic relevance of Mycoplasma felis PCR detection in feline lower respiratory tract diseases

ESVIM-O-9

15.25-15.40

Johnston

Comparison of C-reactive protein with other markers of inflammation in dogs with meningoencephalitis of unknown origin and steroid responsive meningitis-arteritis

ESVIM-O-10

15.40-15.55

Petitpre

Evaluation of C-reactive protein assay in canine bronchoalveolar lavage fluid as a biomarker of bacterial bronchopneumopathy in dogs: A multicenter prospective study.

ESVIM-O-11

16.30-16.45

Reguera Burgos

Donor and Unit-Specific Factors Influencing Hemolysis in Stored Canine and Feline Packed Red Blood Cells

ESVIM-O-12

16.45-17.00

Broughton

Anaemic retinopathy in a referral population of anaemic cats

ESVIM-O-13

17.00-17.15

Beriot

General health quality-of-life questionnaires reveal subtle behavioural changes in undiagnosed hypertensive older cats

ESVIM-O-14

17.15-17.30

Meler

Drivers and challenges of modern clinical education in veterinary teaching hospitals: Using causal loop modelling to understand better the complexity of interactions at play within academic hospitals and within the broader University system.

ESVIM-O-15

17.30-17.45

Knopf

Causes and outcome of systemic inflammatory response syndrome (SIRS) in dogs – analysis of 172 cases

ESVIM-O-16

17.45-18.00

Bouzouraa

Long-term follow-up of dogs treated with a chlorambucil-prednisolone combination for Steroid-Responsive Meningitis-Arteritis: a Prospective study of 12 cases.

ISCAID - International Society for Companion Animal Infectious Diseases

Friday 6 September

ISCAID-O-1

14.25-14.40

Zwicklbauer

Characterization of the lymphocyte response in cats with feline infectious peritonitis during antiviral treatment using the SMART Tube technology for flow cytometry in feline full blood samples

ISCAID-O-2

14.40-14.55

Meli

Alpha-1-acid glycoprotein quantification via spatial proximity analyte reagent capture luminescence assay – validation and application as diagnostic and prognostic marker in serum and effusions of cats with feline infectious peritonitis during GS-441524 treatment

ISCAID-O-3

14.55-15.10

Wenk

Feline coronavirus loads and presence of co-infections in cats diagnosed with feline infectious peritonitis

ISCAID-O-4

15.10-15.25

Cerna

Assessment of cardiac changes in cats with feline infectious peritonitis

ISCAID-O-5

15.25-15.40

Schlachet

Unlicensed antiviral treatment with GS-441524: How are clinicians approaching feline infectious peritonitis in primary care practices ?

ISCAID-O-6

15.40-15.55

Buchta

Shorter treatment duration of 42 days with oral GS-441524 also leads to complete remission in cats with feline infectious peritonitis

ISCAID-O-7

15.55-16.10

Bergamo

Isolation of canine Leptospira Australis strains from the field in view of vaccine development

ISCAID-O-8

16.30-16.45

Schmitt

Comparison of 5 different Leptospira spp. antibody point-of-care test results in healthy dogs after vaccination against leptospirosis

ISCAID-O-9

16.45-17.00

Griebsch

Serovar Australis replaces serovar Copenhageni as the most common serovar causing Canine Leptospirosis in New South Wales, Australia - a case series (2021-2023)

ISCAID-O-10

17.00-17.15

Lecot

Potential leptospiral shedding in vaccinated and asymptomatic pack hounds: a prospective study in 56 dogs.

ISCAID-O-11

17.15-17.30

Evason

Giardia assemblages with zoonotic potential are more commonly found in cats than in dogs in fecal molecular diagnostic test samples collected from the US, Canada, Asia, and Brazil

ISCAID-O-12

17.30-17.45

Sørensen

Evaluation of attitudes and behaviours related to antimicrobial prescribing in canine acute diarrhoea using discrete choice experiments

ISCAID-O-13

17.45-18.00

Belshaw

Poor awareness amongst residents in the United Kingdom (UK) of the canine and human health risks associated with imported puppies carrying non-endemic diseases

ISCAID-O-14

18.00-18.15

Mauron

Effectiveness of the implementation of a revised hygiene concept on hand hygiene compliance and colonisation of hospitalized cats and dogs with multidrug-resistant organisms

ESVONC – European Society of Veterinary Oncology

Friday 6 September 2024

ESVONC-O-1

15.10-15.25

Faroni

A phase 2, single-arm, open-label clinical trial on adjuvant peptide-based vaccination in dogs with biologically aggressive melanoma undergoing tumor excision and lymphadenectomy

ESVONC-O-2

15.25-15.40

Ubiali

CD47 in canine round-cell tumors: an explorative flow cytometric assessment

ESVONC-O-3

15.40-15.55

Maga

Evaluation of risk factors for the development of canine Diffuse Large B-Cell Lymphoma in northern Italy

ESVONC-O-4

16.30-16.45

Mourou

Clinico-hematological profile and outcomes of acute leukemias/myelodysplastic syndromes in cats: a retrospective study of 24 cases

ESVONC-O-5

16.45-17.00

Vigouroux

Tolerability and short term efficacy of intra-arterial vinblastine for the treatment of naturally occurring lower urinary tract carcinomas in dogs

ESVONC-O-6

17.00-17.15

Lane

Bilateral anal sacculectomy in the management of apocrine gland anal sac adenocarcinoma: a retrospective assessment

ESVONC-O-7

17.15-17.30

Coppola

Presentation and treatment of feline HSA in the UK 2009-2024: a retrospective study of 74 cases.

ESVONC-O-8

17.30-17.45

Kapturska

New hope in the treatment of canine hemangiosarcoma – potentiation of doxorubicin with Poly (ADP-ribose) polymerase inhibitors and repurposed propranolol

ESVONC-O-9

17.45-18.00

Rolf

Histopathological growth pattern may predict survival in dogs with splenic haemangiosarcoma post surgery; a case-control pilot study.

ESVE – European Society of Veterinary Endocrinology

Saturday 7 September

ESVE-O-1

08.15-08.30

Didier

Experiences with flash glucose monitoring system in dogs and cats: a global survey of veterinary practitioners.

ESVE-O-2

08.30-08.45

Del Baldo

Assessment of serum fructosamine and glycated hemoglobin as indicators of glycemic control in diabetic dogs: a comparative study using FreeStyle Libre-derived metrics

ESVE-O-3

08.45-09.00

Miceli

Cabergoline for the treatment of feline hypersomatotropism without concurrent diabetes mellitus

ESVE-O-4

09.00-09.15

Kaemper

Does hypophysectomy cause oxytocin deficiency in cats?

ESVE-O-5

09.15-09.30

Stammeleer

Is Follow-Up Thyroid Scintigraphy Useful in Hyperthyroid Cats Treated with Radioiodine?

ESVE-O-6

09.30-09.45

Lin

Large-scale screening for cases of suspected spontaneous hypothyroidism in adult cats and description of clinical, laboratory, scintigraphic features and treatment in four affected cats

ESVE-O-7

09.45-10.00

Hulsebosch

Clinical and Laboratory Characterization of Congenital Hypothyroidism in 23 Kittens 

ESVE-O-8

10.00-10.15

Schwens

Measurement of reverse triiodothyronine concentrations in healthy dogs, dogs with primary hypothyroidism and nonthyroidal illness syndrome.

ESVE-O-9

10.15-10.30

Miceli

Quantitative thyroid scintigraphy for the diagnosis of subclinical hypothyroidism in dogs

ESVE-O-10

11.20-11.35

Rossi

Re-evaluating diagnostic cut-off values: impact of Immulite-2000-antibody change on canine hypercortisolism diagnosis using low-dose dexamethasone suppression test

ESVE-O-11

11.35-11.50

Meunier

Implementing salivary cortisol testing in a clinical setting: feasibility and usefulness of at-home salivary sampling to monitor trilostane treatment in dogs with Cushing’s syndrome

ESVE-O-12

11.50-12.05

Torrano Guillamón

Performance of an In-Clinic Point-of-Care Cortisol Immunoassay for dogs with hypoadrenocorticism.

ESVE-O-13

12.05-12.20

Da Silva

Potential factors that influence adrenocorticotropic hormone stimulation test results in suspect addisonian dogs

ESVE-O-14

12.20-12.35

van den Berg

Canine pheochromocytoma organoids: an in vitro model to explore new treatment options

ESVE-O-15

12.35-12.50

van Bokhorst

Steroid profiling in canine adrenocortical incidentalomas

ESVCN – European Society of Veterinary Comparative  Nutrition

Saturday 7 September

ESVCN-O-1

08.00-08.15

Carciofi

Amino acid supplementation preserves protein turnover rate in obese dogs under weight loss

ESVCN-O-2

08.15-08.30

Carciofi

Protein turnover of overweight and non-overweight cats fed high starch or high protein kibble diets

ESVCN-O-3

08.30-08.45

Henríquez

Environmental impacts of extruded or homemade dog foods determined by Life Cycle Assessment (LCA)

ESVCN-O-4

08.45-09.00

Vecchiato

Hermetia illucens diet improved gut microbial metabolic activity in healthy dogs

ESVCN-O-5

09.00-09.15

de Souza Theodoro

Urine as alternative fluid for the Doubly Labelled Water method use in dogs with Chronic Kidney Disease (preliminary evaluation)

ESVCN-O-6

09.15-09.30

De Souza Theodoro

Hydrolyzed poultry byproduct meal effects on inflammatory and lipid parameters of dogs

ESVCN-O-7

09.30-09.45

Kavanagh

Ultra-low fat home cooked diets improve clinical scores and albumin in dogs with protein losing enteropathy refractory to standard management with low fat diets and immunomodulation

ESVCN-O-8

09.45-10.00

Amundson

High calorie, nutrient dense diet supports body weight in dogs with malignant cancer

ESVCN-O-9

10.00-10.15

Paßlack

Impact of the dietary supplementation of sunflower oil, fish oil and lard on the urine composition and selected blood values of healthy adult cats

ESVCN-O-10

10.15-10.30

Pignataro

Analysis of the impact of nutritional supplementation on canine gut microbiota through an in vitro colonic fermentation model